Bank of New York Mellon Corp Purchases 943 Shares of ZimVie Inc. (NASDAQ:ZIMV)

Bank of New York Mellon Corp boosted its stake in ZimVie Inc. (NASDAQ:ZIMV) by 0.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 100,638 shares of the company’s stock after acquiring an additional 943 shares during the period. Bank of New York Mellon Corp’s holdings in ZimVie were worth $1,404,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. SG Americas Securities LLC boosted its holdings in ZimVie by 15.7% in the fourth quarter. SG Americas Securities LLC now owns 11,110 shares of the company’s stock valued at $155,000 after acquiring an additional 1,508 shares during the last quarter. EMC Capital Management boosted its holdings in ZimVie by 47.0% in the fourth quarter. EMC Capital Management now owns 13,802 shares of the company’s stock valued at $193,000 after acquiring an additional 4,414 shares during the last quarter. Principal Financial Group Inc. bought a new stake in ZimVie in the third quarter valued at approximately $275,000. Dynamic Technology Lab Private Ltd bought a new stake in ZimVie in the third quarter valued at approximately $470,000. Finally, Y Intercept Hong Kong Ltd bought a new stake in ZimVie in the third quarter valued at approximately $528,000. 95.63% of the stock is currently owned by institutional investors.

ZimVie Price Performance

Shares of ZIMV opened at $11.66 on Monday. ZimVie Inc. has a 52-week low of $11.35 and a 52-week high of $22.40. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94. The business’s 50 day moving average price is $13.31 and its two-hundred day moving average price is $14.20. The firm has a market cap of $322.71 million, a PE ratio of -0.89 and a beta of 2.10.

ZimVie (NASDAQ:ZIMV) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.02. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. The firm had revenue of $111.52 million for the quarter, compared to analyst estimates of $113.67 million. On average, equities analysts anticipate that ZimVie Inc. will post 0.6 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Needham & Company LLC reiterated a “hold” rating on shares of ZimVie in a report on Thursday, March 13th.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.